Here are five key notes:
1. NuVasive anticipates revenue will reach around $811 million in 2015, a 6 percent increase over 2014. This is close to the $810 million the company previously issued as guidance for the full year.
2. In the fourth quarter, NuVasive anticipates reaching $215 million.
3. NuVasive expects the full year 2015 non-GAAP operating profit margin to exceed the previous financial performance guidance of around 15.2 percent.
4. NuVasive recently acquired Ellipse Technologies, driving company growth. Margin expansion is expected as the company reaches past $1 billion in revenue.
5. The Ellipse Technologies transaction is expected to close in February 2016 and NuVasive expects to update its full year and long-term financial performance guidance to reflect the acquisition.
More articles on orthopedic devices:
K2M 2015 preliminar revenue up 16%: 5 key notes
Tax on medical device company revenue suspended: 3 key points
Is your medical device hacked? 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
